Navigation Links
Microscopic Nanobombs Blow Apart Breast Cancer Cells

Researchers at the University of Delaware have developed a unique nanobomb that can be used to detect and blow apart cancer cells, more specifically breast cancer cells//.

This latest attack on cancer has been detailed in the journals NanoBiotechnology and Oncology Issues by Balaji Panchapakesan, assistant professor of electrical and computer engineering at UD. The report says that the nanobomb technology is still in its infancy and that it would be many years before it became an actual reality.

Panchapakesan says that the nanobombs were a byproduct of extensive work with carbon nanotubes for the last two years. The main aim of the project was to see if these nanotubes could be used as drug delivery vehicles. "When you put the atoms in different shapes and forms, they take on different properties at the nanoscale," Panchapakesan said. "We were experimenting with the molecules and considering optical and thermal properties, and found we could trigger microscopic explosions of nanotubes in wide variety of conditions." When the other researchers saw these nano explosions, they came up with the idea of using them against cancer cells.

"The nanobomb is very selective, very localized and minimally invasive," Panchapakesan said. "It might cause what I would call nanopain, like a pin prick." He is of the opinion that this therapy would be particularly effective against breast cancer since the shockwaves generated by the explosions kill "the cancerous cells as well as the biological pathways that carry instructions to generate additional cancerous cells."

Panchapakesan said that they were working to direct these therapies towards treating breast cancer, prostate cancer and pancreatic cancer.
'"/>




Page: 1

Related medicine news :

1. Microscopic lens monitors heart problems
2. Microscopic Grains Used in Sun Block Creams may Cause Nerve Damage
3. Neck Artery Treatment Apart From Clearing Plaques Boosts Memory
4. Apartment Dwellers Live Dangerously
5. Come Apart and Rest Awhile – It’s Christma!
6. Consensus on "Combination Therapy" for Breast Cancer
7. Breast cancer treatment to be determined by gene test
8. Breast Feeding prevents obesity later on in life
9. Breast milk is essential
10. Breast Cancer Surgery Causes Psychological problems
11. Breast cancer evidence
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... Albuquerque, NM (PRWEB) , ... December 06, 2016 ... ... awarded JumpStart Autism Center with an Award of Distinction, recognizing the organization as ... needs providers that excel in the areas of clinical quality, staff satisfaction and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind ... design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:12/6/2016)... Georgia (PRWEB) , ... December 06, 2016 , ... ... consecutive year to "Training" magazine’s 2017 Training Top 125 for their industry leading ... This prestigious, annual award recognizes USA as among the global elite in employer-sponsored ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - InMed Pharmaceuticals, ... today on its R&D program in the use ... pulmonary disease (COPD). In June, 2015 InMed initiated ... to identify the targets and potential active compounds ... COPD. Subsequently, with in vitro assays using human ...
(Date:12/5/2016)... WARSAW, Ind. , Dec. 5, 2016  Zimmer ... "Company") today announced that, pursuant to its previously-announced ... securities identified in the table below (collectively, the ... Notes were validly tendered and not validly withdrawn ... York City time, today, December 5, ...
(Date:12/5/2016)... 5, 2016 Sangamo BioSciences, Inc. (Nasdaq: ... presentation of preclinical and manufacturing data that support SB-525, its ... Annual Meeting of the American Society of Hematology (ASH) ... from December 3-6, 2016. "We have developed an ... we believe is highly competitive, and we remain on track ...
Breaking Medicine Technology: